Theranexus (EPA:ALTHX) | Finanzwire

Basculer en Français

10596	Companies
224704	Keywords
153398	Articles
118849	Press releases

Home
Companies
Theranexus

BRIEF

published on 09/29/2025 at 18:35, 8 months 18 days ago

THX Pharma: a strategic evolution towards international expansion

Growth Strategy Rare Diseases THX Pharma International Marketing Drugs TX01 And Batten-1
PRESS RELEASE

published on 09/29/2025 at 18:30, 8 months 18 days ago

Theranexus Becomes THX Pharma: A Strategic Evolution Toward the Commercialization of Its Medicines for Rare Diseases
THX Pharma (formerly Theranexus) announces strategic focus on regulatory approval, early access, and global commercialization of new drug candidates for rare neurological diseases

Regulatory Approval Commercialization Rare Neurological Diseases THX Pharma Early Access
BRIEF

published on 09/25/2025 at 18:05, 8 months 22 days ago

Theranexus publishes its financial results for the first half of 2025

Financial Results Cost Reduction Theranexus Batten-1 TX01
PRESS RELEASE

published on 09/25/2025 at 18:00, 8 months 22 days ago

THERANEXUS ANNOUNCES FIRST HALF 2025 FINANCIAL RESULTS
Theranexus announces first half 2025 financial results showing a decrease in operating expenses and a net loss of €1,072 K. Focus on developing flagship asset TX01 and advancing Batten-1

Financial Results Theranexus Batten-1 Operating Expenses TX01
BRIEF

published on 07/17/2025 at 18:05, 11 months ago

Half-Yearly Review of the Theranexus Liquidity Contract

Liquidity Contract PORTZAMPARC Financial Statement Biopharmaceuticals Theranexus
BRIEF

published on 07/10/2025 at 18:05, 11 months 7 days ago

Theranexus Reveals its Cash Position as of June 30, 2025

Treasury Biopharmaceutical Innovation Theranexus Batten-1 Neurological Diseases
PRESS RELEASE

published on 07/10/2025 at 18:00, 11 months 7 days ago

THERANEXUS PUBLISHES ITS CASH POSITION AS OF 30 JUNE 2025
Theranexus, a biopharmaceutical company, reports a cash position of €2.1M as of 30 June 2025, with upcoming funds and financial visibility through Q2 2026. CEO discusses collaborations and strategic progress. H1 2025 results expected on September 25, 2025

Cash Position Biopharmaceutical Financial Publication Theranexus Rare Neurological Diseases
BRIEF

published on 05/13/2025 at 18:05, 1 year 1 month ago

Theranexus and BBDF reveal promising results for Batten-1

Theranexus Batten-1 BBDF Batten Disease Visual Acuity
PRESS RELEASE

published on 05/13/2025 at 18:00, 1 year 1 month ago

THERANEXUS AND BEYOND BATTEN DISEASE FOUNDATION ANNOUNCE STRONG POSITIVE REAL-WORLD DATA SUPPORTING BATTEN-1 EFFICACY FOR THE TREATMENT OF BATTEN DISEASE
Theranexus and BBDF announce new data supporting Batten-1 (miglustat) efficacy for CLN3 disease treatment. Results show significant preservation of visual acuity in treated patients over 12 months. Real-world analysis aligns with Phase 3 trial design

Theranexus Batten-1 BBDF Visual Acuity CLN3 Disease
BRIEF

published on 04/29/2025 at 19:05, 1 year 1 month ago

Theranexus: 2024 Annual Review and New Perspectives

Financial Results Partnerships Theranexus Batten-1 Grants

Accesswire

Published on 06/18/2026 at 13:30, 27 minutes ago

Spirit Blockchain Capital Announces Shares For Services Issuance
Published on 06/18/2026 at 13:30, 27 minutes ago

ZTEST Electronics Inc. Announces Leadership Transition, Appoints New Director and Chair
Published on 06/18/2026 at 13:00, 57 minutes ago

Formation Metals Extends A-Zone 200 Metres West of Historic Resource into Previously Undrilled Ground, Returning 1.05 g/t Au over 31 Metres at the Advanced N2 Gold Project
Published on 06/18/2026 at 13:00, 57 minutes ago

Silver Storm Receives La Parrilla Surface Drilling Permits
Published on 06/18/2026 at 12:30, 1 hour 27 minutes ago

Relevant Gold South Pass VTEM Survey Defines Multi-Kilometre Structural Corridors with High Priority Drill Targets

View all ACCESSWIRE

EQS Group

Published on 06/18/2026 at 13:05, 52 minutes ago

Claros Technologies Appoints Jack Cogen to Board of Directors
Published on 06/18/2026 at 13:05, 52 minutes ago

MMDSmart MessageWhiz Launches On Zoho Marketplace To Extend Automated Omnichannel Messaging Inside Zoho CRM
Published on 06/18/2026 at 12:55, 1 hour 2 minutes ago

FP Markets Wins Most Trusted Broker at the Global UF Awards 2026
Published on 06/18/2026 at 12:45, 1 hour 12 minutes ago

Hong Kong rises to No.2 globally in competitiveness
Published on 06/18/2026 at 12:12, 1 hour 45 minutes ago

Form 8.3 - Advanced Medical Solutions Group Plc

Les Echos

Published on 06/18/2026 at 13:00, 57 minutes ago

Edenred statement
Published on 06/18/2026 at 09:06, 4 hours 51 minutes ago

Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany
Published on 06/18/2026 at 08:30, 5 hours 27 minutes ago

OPmobility wins first awards with Chinese automaker Leapmotor outside of China
Published on 06/18/2026 at 07:00, 6 hours 57 minutes ago

bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry
Published on 06/17/2026 at 17:40, 20 hours 17 minutes ago

Report on share repurchases from 10 to 16 June 2026

View all LES ECHOS COMFI WIRE